The Alterations in Some Salivary Biomarkers and Oral Microbiome in COVID-19 Patients and Healthy Individuals
Author(s): Mustafa Kareem Aziz* and Abbas S Al-Mizraqchi
Abstract
A saliva samples have been collected from 42 COVID-19 patient and a 42 healthy individuals and tested for salivary biomarkers of, α-amylase, lysozyme in addition to and mutans streptococci. Results showed non-significant difference between mean concentration of α-amylase in COVID-19 patients (5.48 µ/ml) and healthy individuals (6.05 µg/ml), high significant difference in mean concentration of lysozyme in COVID-19 patient (170.42 µg/ml) and healthy individuals (8.47 µg/ml), and non-significant difference in mean concentration of mutans streptococci in COVID-19 patients (6.88) × 10? CFU/ml and healthy individuals (6.58 × 10? CFU/ml).